|

Mirvetuximab Soravtansine-gynx Clinical Trials

1 actively recruiting trial across 1 location

Also known as: IMGN853, MIRV

Pipeline

Phase 2: 1

Top Sponsors

  • University of Colorado, Denver1

Indications

  • Peritoneal Cancer1
  • Fallopian Tube Cancer1
  • Ovary Cancer1
  • Cancer1

Aurora, Colorado1 trial

An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib

University of Colorado Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.